Content:
• Analysis of residues of hormones and hormonally active substances in animal-based matrices, illustrated by using selected methods
• Hormones and hormonally active substances, as well as their metabolites as potential residues
• Validation of analytical methods in line with EU criteria (Commission Decision 2002/657/EC)
• Requirements for screening and validation methods in line with Commission Decision 2002/657/EC
• Overview over the legal framework within the EU
• Sample receipt and management; sample registration via database system
• Laboratory infrastructure – room, equipment
• Laboratory staff qualifications
• Quality management, proficiency tests
• Reporting
• Discussing the specific requirements of the participants
Team:
Georg MAYERHOFER, Dr. (Head of the Department for Veterinary Drugs, Hormones and Contaminates)
Johann BURGER, MSc (Head of the Group Hormones and Banned Veterinary Drugs)
Martin BRANDTNER, Dr. (Head of the Group Veterinary Drugs)